|
|
Y Guan, Y Zhang, R M Breyer, B Fowler, L Davis, R L Hébert, M D Breyer
J Clin Invest. 1998;
102(1):194
doi:10.1172/JCI2872
Abstract |
Full text
| PDF

P
GE2 exerts potent diuretic and natriuretic effects on the kidney. This action is mediated in part by direct inhibition of collecting duct Na+ absorption via a Ca++-coupled mechanism. These studies examine the role the Ca++-coupled PGE-E EP1 receptor plays in mediating these effects of PGE2 on Na+ transport. Rabbit EP1 receptor cDNA was amplified from rabbit kidney RNA. Nuclease protection assays demonstrated highest expression of EP1 mRNA in kidney, followed by stomach, adrenal, and ileum. In situ hybridization, demonstrated renal expression of EP1 mRNA was exclusively over the collecting duct. In fura-2-loaded microperfused rabbit cortical collecting duct, EP1 active PGE analogs were 10-1, 000-fold more potent in raising intracellular Ca++ than EP2, EP3, or EP4-selective compounds. Two different EP1 antagonists, AH6809 and SC19220, completely blocked the PGE2-stimulated intracellular calcium increase. AH6809 also completely blocked the inhibitory effect of PGE2 on Na+ absorption in microperfused rabbit cortical collecting ducts. These studies suggest that EP1 receptor activation mediates PGE2-dependent inhibition of Na+ absorption in the collecting duct, thereby contributing to its natriuretic effects.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(28)
| Title and authors |
Publication |
Year |
Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus
E. T. B. Olesen, M. R. Rutzler, H. B. Moeller, H. A. Praetorius, R. A. Fenton
|
Proceedings of the National Academy of Sciences
|
2011 |
Effect of PGE2 on DA tone by EP4 modulating Kv channels with different oxygen tension between preterm and term
Fenling Fan, Aiqun Ma, Youfei Guan, Jianhua Huo, Zhi Hu, Hongyan Tian, Lihong Chen, Sen Zhu, Lihong Fan
|
International Journal of Cardiology
|
2011 |
Comprehensive Physiology
Raymond C. Harris, Ming-Zhi Zhang
|
Comprehensive Physiology
|
2011 |
Burger's Medicinal Chemistry and Drug Discovery
Adrian Hall, Simon Peace, Martin E. Swarbrick
|
Burger's Medicinal Chemistry and Drug Discovery
|
2010 |
Aldosterone glucuronidation by human liver and kidney microsomes and recombinant UDP-glucuronosyltransferases: Inhibition by NSAIDs
Kathleen M. Knights, Leanne K. Winner, David J. Elliot, Kushari Bowalgaha, John O. Miners
|
British Journal of Clinical Pharmacology
|
2009 |
Effects of Lipids on ENaC Activity in Cultured Mouse Cortical Collecting Duct Cells
Su Wang, Fei Meng, Jingyuan Xu, Yuchun Gu
|
J Membrane Biol
|
2009 |
E Prostanoid-1 receptor regulates renal medullary αENaC in rats infused with angiotensin II
Alexis A. González, Carlos Céspedes, Sandra Villanueva, Luis Michea, Carlos P. Vio
|
Biochemical and Biophysical Research Communications
|
2009 |
Physiological Regulation of Prostaglandins in the Kidney
Chuan-Ming Hao, Matthew D. Breyer
|
Annu. Rev. Physiol.
|
2008 |
PGE2 inhibits basolateral 50 pS potassium channels in the thick ascending limb of the rat kidney
Ruimin Gu, Yan Jin, Yuanyuan Zhai, Lei Yang, Chengbiao Zhang, Wennan Li, lijun Wang, Shumin Kong, Yunhong Zhang, Baofeng Yang, Wen-Hui Wang
|
Kidney Int
|
2008 |
Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting
Youfei Guan, Yahua Zhang, Jing Wu, Zhonghua Qi, Guangrui Yang, Dou Dou, Yuansheng Gao, Lihong Chen, Xiaoyan Zhang, Linda S. Davis, Mingfeng Wei, Xuefeng Fan, Monica Carmosino, Chuanming Hao, John D. Imig, Richard M. Breyer, Matthew D. Breyer
|
J. Clin. Invest.
|
2007 |
|